Sage Therapeutics director Jeffrey M. Jonas to retire from Board effective Dec 1, 2024

Sage Therapeutics, Inc.

Jeffrey M. Jonas notified the Board of his retirement effective December 1, 2024.
Retirement not due to any disagreement with the Company on operations, policies, or practices.
Jonas served as a member of the Board prior to retirement.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Jeffrey M. Jonas

member of the Board of Directors

Sage Therapeutics, Inc.

Effective: 2024-12-01
Filed: November 26, 2024, 6:59 PM ET

On November 22, 2024, Jeffrey M. Jonas, MD, a member of the Board of Directors (the “Board”) of Sage Therapeutics, Inc. (the “Company”), notified the Company of his retirement from the Board, effective as of December 1, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Jeffrey M. Jonas retired as member of the Board of Directors at Sage Therapeutics, Inc..

Action: retired
Role: member of the Board of Directors

Exact text from the filing

On November 22, 2024, Jeffrey M. Jonas, MD, a member of the Board of Directors (the “Board”) of Sage Therapeutics, Inc. (the “Company”), notified the Company of his retirement from the Board, effective as of December 1, 2024.

View on SEC.gov

Source: SEC EDGAR

accession 0001193125-24-266154

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.